Marc Böhning

Marc Böhning currently serves as Principal Scientist in Protein Therapeutics and Structural Biology at Odyssey Therapeutics, where expertise in protein science supports drug discovery programs in immunology and oncology. Prior experience includes a doctoral and postdoctoral researcher role at the Max Planck Institute for Biophysical Chemistry, contributing to significant publications on RNA polymerase II. Academic credentials include a Doctor rerum naturalium in Biochemistry and Molecular Biology and a Master of Science in Molecular Biology from the University of Göttingen, as well as a Bachelor of Science in Biology from the Technical University of Munich. Marc has also held research intern positions focusing on phosphoproteomics and the characterization of novel phosphatase-encoding genes, alongside a Bachelor's thesis related to cellular kinases.